This is a routine periodic disclosure of share repurchase activity. Monitor future filings for completion of the DKK 15 billion program and any changes to the pace of buybacks.
Price Chart
Executive Summary
Novo Nordisk filed a routine 6-K disclosing weekly transactions under its ongoing DKK 15 billion share repurchase program. Since the last announcement on October 19, 2026, the company repurchased approximately 1.2 million B shares for about DKK 312 million, bringing total repurchases under the program to 25.5 million shares for DKK 7.39 billion. The filing is a standard periodic update with no material new information.
Key Facts
- Novo Nordisk repurchased 1,200,000 B shares from October 19-23, 2026, at an average price of DKK 260.27 per share, for a total transaction value of approximately DKK 312.3 million.
- Total repurchases under the program initiated May 6, 2026, stand at 25,515,000 B shares for DKK 7,387,348,112.
- The overall share repurchase program authorizes up to DKK 15 billion over 12 months beginning February 4, 2026; as of October 23, 2026, total repurchases since February 4, 2026, were 40,274,179 B shares for DKK 11,187,348,102.
- Novo Nordisk holds 54,314,876 B shares as treasury shares, representing 1.2% of total share capital of 4,465,000,000 A and B shares.
Financial Impact
Routine weekly update of ongoing share repurchase program; no material financial impact from this filing alone.
Risk Factors
- No material risks identified in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-006813 |
| Document: 0001171843-26-006813-index-headers.html | 0001171843-26-006813 |
| Document: 0001171843-26-006813-index.html | 0001171843-26-006813 |
| Document: 0001171843-26-006813.txt | 0001171843-26-006813 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $38.67 (−1.18%) |
Oct 26, 2026 2d ago | Court Ruling | $38.59 | awaiting T+20 | awaiting T+20 | $38.67 (+0.21%) |
Oct 19, 2026 8d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $38.67 (+0.65%) |
Oct 13, 2026 15d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $38.67 (+1.60%) |
Oct 6, 2026 22d ago | 6-K | $37.53 | awaiting T+20 | awaiting T+20 | $38.67 (+3.04%) |
Sep 28, 2026 29d ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $38.67 (−0.10%) |
Sep 23, 2026 5w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $38.67 (+0.13%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $38.67 (−2.84%) |
Sep 17, 2026 5w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $38.67 (−10.47%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $38.67 (−9.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers